| Literature DB >> 31781383 |
Wei Zhou1, Tao Wang1, Lingjuan Zhu1, Minghua Wen2, Lihua Hu2, Xiao Huang2, Chunjiao You2, Juxiang Li2, Yanqing Wu2, Qinghua Wu2, Huihui Bao2, Xiaoshu Cheng2.
Abstract
BACKGROUND: Association between age at menarche (AAM) and hypertension remains a controversial topic, and data in China were sparse. Therefore, we aimed to investigate the association between AAM and hypertension in Chinese female population.Entities:
Year: 2019 PMID: 31781383 PMCID: PMC6875309 DOI: 10.1155/2019/9473182
Source DB: PubMed Journal: Int J Hypertens Impact factor: 2.420
Figure 1Flow chart of study participants.
Baseline characteristics according to age at menarche.
| Characteristics | Overall | Age at menarche, y |
| |||
|---|---|---|---|---|---|---|
| ≤13 | 14-15 | 16-17 | ≥18 | |||
|
| 5,102 | 869 | 1,749 | 1,578 | 906 | — |
| Enrollment age, y, mean (SD) | 52.6 (17.7) | 50.6 (18.5) | 52.6 (17.6) | 53.2 (17.5) | 53.2 (17.5) | 0.003 |
| Age at menarche, y, mean (SD) | 15.5 (2.1) | 12.6 (0.7) | 14.5 (0.5) | 16.4 (0.5) | 18.7 (1.0) | <0.001 |
| Menopause, | 2700 (52.92%) | 276 (31.76%) | 815 (46.60%) | 956 (60.58%) | 653 (72.08%) | <0.001 |
| Hypertension, | 1,495 (29.3%) | 204 (23.5%) | 427 (24.4%) | 538 (34.1%) | 326 (36.0%) | <0.001 |
| Antihypertensive medication, | 375 (7.4%) | 58 (6.7%) | 101 (5.8%) | 141 (8.9%) | 75 (8.3%) | 0.003 |
| Residence (urban), | 2528 (49.6%) | 430 (49.5%) | 871 (49.8%) | 803 (50.9%) | 424 (46.8%) | 0.271 |
|
| ||||||
|
| 0.370 | |||||
| 0–6 | 2848 (55.8%) | 464 (53.4%) | 961 (54.9%) | 905 (57.4%) | 518 (57.2%) | |
| 7–9 | 1136 (22.3%) | 196 (22.6%) | 394 (22.5%) | 352 (22.3%) | 194 (21.4%) | |
| ≥10 | 1118 (21.9%) | 209 (24.1%) | 394 (22.5%) | 321 (20.3%) | 194 (21.4%) | |
|
| ||||||
|
| 0.033 | |||||
| Unmarried | 502 (9.8%) | 112 (12.9%) | 175 (10.0%) | 138 (8.8%) | 77 (8.5%) | |
| Married | 3915 (76.7%) | 648 (74.6%) | 1332 (76.2%) | 1231 (78.0%) | 704 (77.7%) | |
| Divorced or widowed | 685 (13.5%) | 109 (12.5%) | 242 (13.8%) | 209 (13.2%) | 125 (13.8%) | |
|
| ||||||
|
| 0.860 | |||||
| Never | 5023 (98.4%) | 854 (98.3%) | 1724 (98.5%) | 1550 (98.2%) | 895 (98.8%) | |
| Current | 70 (1.4%) | 13 (1.5%) | 22 (1.3%) | 26 (1.7%) | 9 (1.0%) | |
| Former | 9 (0.2%) | 2 (0.2%) | 3 (0.2%) | 2 (0.1%) | 2 (0.2%) | |
|
| ||||||
|
| 727 (14.3%) | 119 (13.7%) | 245 (14.0%) | 231 (14.6%) | 132 (14.6%) | 0.902 |
|
| 0.008 | |||||
| Low | 660 (12.9%) | 117 (13.5%) | 215 (12.3%) | 180 (11.4%) | 148 (16.3%) | |
| Moderate | 1495 (29.3%) | 265 (30.5%) | 534 (30.5%) | 457 (29.0%) | 239 (26.4%) | |
| Vigorous | 2947 (57.8%) | 487 (56.0%) | 1000 (57.2%) | 941 (59.6%) | 519 (57.3%) | |
| BMI, kg/m2, mean (SD) | 22.8 (3.6) | 22.4 (3.3) | 22.84 (3.6) | 23.0 (3.7) | 22.9 (3.6) | <0.001 |
| WC, cm, mean (SD) | 77.8 (9.6) | 76.8 (9.6) | 77.9 (9.3) | 78.2 (9.6) | 78.0 (9.8) | 0.005 |
| BFP, %, mean (SD) | 30.2 (7.7) | 29.5 (7.6) | 30.1 (8.0) | 30.5 (7.4) | 30.3 (7.6) | 0.035 |
| VAI, mean (SD) | 6.3 (3.7) | 6.0 (3.4) | 6.3 (3.6) | 6.5 (3.8) | 6.4 (4.0) | 0.025 |
| BMR, kcal/day, mean (SD) | 1167.9 (312.0) | 1153.9 (266.8) | 1164.2 (296.3) | 1178.9 (366.8) | 1169.6 (275.5) | 0.265 |
| HR, mean (SD) | 78.8 (11.1) | 78.4 (10.4) | 78.7 (11.0) | 78.9 (11.3) | 79.1 (11.4) | 0.543 |
| SBP, mmHg, mean (SD) | 124.7 (21.6) | 121.6 (19.1) | 122.6 (20.4) | 126.5 (22.5) | 128.5 (23.5) | <0.001 |
| DBP, mmHg, mean (SD) | 72.9 (11.5) | 71.2 (8.9) | 72.14 (11.0) | 73.8 (12.33) | 74.7 (12.6) | <0.001 |
| Sleeping duration, h, mean (SD) | 7.3 (1.6) | 7.3 (1.6) | 7.2 (1.6) | 7.2 (1.7) | 7.2 (1.6) | 0.884 |
BMI = body mass index; BMR = basal metabolism rate; WC = waist circulation; BFP = body fat percentage; VAI = visceral adiposity index; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate.
Analysis of AAM and hypertension.
| AAM |
| Hypertension OR (95% CI), | |||
|---|---|---|---|---|---|
| Cases | Crude | Model 1 | Model 2 | ||
| Continuous variable | 5,102 | 1,495 | 1.13 (1.10, 1.16), <0.001 | 1.14 (1.10, 1.17), <0.001 | 1.15 (1.11, 1.19), <0.001 |
|
| |||||
|
| |||||
| ≤13 y | 869 | 204 | 1.00 | 1.00 | 1.00 |
| 14-15 y | 1,749 | 427 | 1.05 (0.87, 1.27), 0.597 | 0.97 (0.78, 1.20), 0.765 | 0.95 (0.76, 1.19), 0.681 |
| 16-17 y | 1,578 | 538 | 1.69 (1.40, 2.04), <0.001 | 1.65 (1.43, 2.02), <0.001 | 1.68 (1.34, 2.11), <0.001 |
| ≥18 y | 906 | 326 | 1.83 (1.49, 2.25), <0.001 | 1.89 (1.50, 2.40), <0.001 | 2.01 (1.56, 2.58), <0.001 |
|
| — | — | <0.001 | <0.001 | <0.001 |
| ≤15 y | 2,618 | 631 | |||
| 16-17 y | 1,578 | 538 | 1.63 (1.42, 1.87), <0.001 | 1.68 (1.44, 1.97), <0.001 | 1.74 (1.48, 2.05), <0.001 |
| ≥18 y | 906 | 326 | 1.77 (1.50, 2.08), <0.001 | 1.94 (1.61, 2.33), <0.001 | 2.08 (1.71, 2.53), <0.001 |
|
| — | — | <0.001 | <0.001 | <0.001 |
Model 1 included enrollment age, residence, education, and marital status for adjustment. Model 2 included enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration. BMI = body mass index; BMR = basal metabolism rate; WC = waist circulation; BFP = body fat percentage; VAI = visceral adiposity index; HR = heart rate.
Figure 2Multivariate adjusted smooth curve of hypertension by AAM. The solid line represents the estimated values, and the dashed line represents the 95% CI. Adjusted for enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration.
Analysis of AAM and SBP, and DBP in females with hypertension.
| AAM, y |
| Mean (SD) |
| ||
|---|---|---|---|---|---|
| Crude | Model 1 | Model 2 | |||
|
| |||||
| Continuous variable, y | 1,495 | 146.9 (24.3) | 0.86 (0.28, 1.45), 0.004 | 0.98 (0.40, 1.56), 0.001 | 0.88 (0.29, 1.46), 0.003 |
| Categorical variables | |||||
| ≤15 y | 631 | 144.5 (25.6) | 0 | 0 | 0 |
| 16-17 y | 538 | 147.8 (23.0) | 3.32 (0.54, 6.10), 0.020 | 3.72 (0.95, 6.49), 0.009 | 3.50 (0.72, 6.27), 0.014 |
| ≥18 y | 326 | 150.2 (23.3) | 5.67 (2.44, 8.90), 0.001 | 6.41 (3.20, 9.63), <0.001 | 5.84 (2.62, 9.05), <0.001 |
|
| — | — | <0.001 | <0.001 | <0.001 |
|
| |||||
|
| |||||
| Continuous variable | 1,495 | 80.6 (14.4) | 0.86 (0.52, 1.21), <0.001 | 0.88 (0.54, 1.22), <0.001 | 0.80 (0.47, 1.13), <0.001 |
| Categorical variables | |||||
| ≤15 y | 631 | 78.2 (14.7) | 0 | 0 | 0 |
| 16-17 y | 538 | 82.3 (13.9) | 4.07 (2.43, 5.71), <0.001 | 4.09 (2.48, 5.71), <0.001 | 3.35 (1.81, 4.88), <0.001 |
| ≥18 y | 326 | 82.7 (13.9) | 4.50 (2.60, 6.41), <0.001 | 4.54 (2.66, 6.42), <0.001 | 4.34 (2.53, 6.16), <0.001 |
|
| — | — | <0.001 | <0.001 | <0.001 |
Model 1 adjusted for enrollment age, residence, education, and marital status for adjustment. Model 2 adjusted for enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration. BMI = body mass index; BMR = basal metabolism rate; WC = waist circulation; BFP = body fat percentage; VAI = visceral adiposity index; HR = heart rate.
Figure 3Effect size of AAM on hypertension in each subgroup. Adjusted, if not stratified, for enrollment age, residence, education, marital status, smoking, drinking, menopause, antihypertensive medication, physical activity, BMI, WC, BFP, VAI, BMR, HR, and sleeping duration.